欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/H/1324/004
药品名称Octreotida Hospira
活性成分
    • Octreotide acetate 500.0 µg/ml
剂型Solution for injection
上市许可持有人Laboratórios Pfizer, Lda. Lagoas Park, Edifício 10 2740-271 - Porto Salvo - Porto Salvo - PT
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
许可日期2008/04/05
最近更新日期2025/07/14
药物ATC编码
    • H01CB02 octreotide
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase